Patient demographics and psychotropic medication prescribing in Australian general practices: pre- and during COVID-19 pandemic
Open Access
- 19 February 2024
- journal article
- research article
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 16 (4) , 325-331
Abstract
Introduction: Mental health conditions, such as depression, anxiety, and psychological distress in the adult population significantly increased during the COVID-19 pandemic. However, the rates of prescribing psychotropic medications in adults during the COVID-19 period have not been well explored. Aim: The aim of this study was to examine the association between demographic characteristics and rates of prescribing psychotropic medications to general practice patients during 2018–2022. Methods: A total of 154 528 general practice patients aged 20 years and above were included in the study. A mixed effects negative binomial regression model was employed and incidence risk ratios (IRRs) with corresponding 95% confidence interval (CI) are presented to measure the association of demographic characteristics with rates of prescribing psychotropic medication. Results: Over half (56.2%) of study subjects were female and 41.4% were aged between 20 and 39 years. Males had lower prescribing rates of antidepressants (IRR = 0.95; 95% CI: 0.94, 0.97) and hypnotics and sedatives (IRR = 0.97; 95% CI: 0.96, 0.99) than females. People in the age group 60+ years (compared with age group 20–39 years) and those in low and middle socio-economic status (SES) categories (compared with high SES) had higher rates of prescribing psychotropic medication. Conclusion: Females, people aged 60+ years, and people with low and middle SES had higher prescribing rates of psychotropic medication. A consistent increase in prescribing rates over time, particularly during the COVID-19 pandemic, was observed. It is important that health care planners and policy makers monitor and account for population diversity and equity.Keywords
Funding Information
- Digital Health Cooperative Research Centre (01180)
This publication has 21 references indexed in Scilit:
- The impact of COVID-19 on antidepressant sales and prescription dispensing in AustraliaAustralian & New Zealand Journal of Psychiatry, 2021
- Psychotropic medication prescribing during the COVID-19 pandemicMedicine, 2021
- National Survey on the Impact of COVID-19 on the Mental Health of Australian Residential Aged Care Residents and StaffClinical Gerontologist, 2021
- Stress and Coping in Older Australians During COVID-19: Health, Service Utilization, Grandparenting, and Technology UseClinical Gerontologist, 2021
- COVID-19 pandemic and mental health consequences: Systematic review of the current evidenceBrain, Behavior, and Immunity, 2020
- The Impact of Covid-19 Experiences and Associated Stress on Anxiety, Depression, and Functional Impairment in American AdultsCognitive Therapy and Research, 2020
- Gender Differences in Psychotropic Use Across Europe: Results From a Large Cross-Sectional, Population-Based StudyEuropean Psychiatry, 2015
- The relationship between socio-economic status and antidepressant prescription: a longitudinal survey and register study of young adultsEpidemiology and Psychiatric Sciences, 2011
- Unexplained Variation Across US Nursing Homes in Antipsychotic Prescribing RatesArchives of internal medicine (1960), 2010
- Gender and Psychotropic Drug UseMedical Care, 1998